BackProgenity Overview

Progenity Receivables

Track Progenity's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-818000.00 vs prior year quarter

Peer average

Loading

Progenity Receivables History

Loading

Progenity vs. peers: Receivables Comparison

Loading

Progenity Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Progenity (PROG) FAQ

Progenity (PROG) currently reports a receivables of $0 as of September 2024. That compares with $820K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Progenity's receivables history and peer comparisons.

Progenity's receivables decreased from $820K to $0 — a 100.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Progenity reported $0 in receivables as of September 2024. That compares with $820K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Progenity, and consider following PROG for alerts when major investors trade the stock.

Progenity is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PROG with unrelated industries.